Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2021

Jul 16, 2021

32641_dirs_2021-07-16_c3df620d-15cf-4142-9b0e-aeda56d5b674.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2021-07-15

Reporting Person: FALLON LYNNETTE C (Director)